These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9597781)

  • 1. Primary biliary cirrhosis: ursodiol effective, but think transplantation sooner.
    Carithers RL
    Cleve Clin J Med; 1998 Apr; 65(4):174-6. PubMed ID: 9597781
    [No Abstract]   [Full Text] [Related]  

  • 2. Ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B
    Semin Liver Dis; 1997 May; 17(2):125-8. PubMed ID: 9170199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
    Thimme R; Opitz OG; Kreisel W
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1823-6. PubMed ID: 12215926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary biliary cirrhosis].
    Corpechot C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):320-4. PubMed ID: 12700520
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
    Corpechot C; Chazouilleres O
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
    [No Abstract]   [Full Text] [Related]  

  • 7. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 8. How, why, and when does primary biliary cirrhosis recur after liver transplantation?
    Williams R; Gershwin ME
    Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary biliary cirrhosis (PBC)].
    Rautiainen H
    Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems.
    Goel A; Kim WR
    Clin Liver Dis; 2018 Aug; 22(3):563-578. PubMed ID: 30259853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom.
    Corpechot C; Poupon R
    Hepatology; 2007 Oct; 46(4):963-5. PubMed ID: 17894325
    [No Abstract]   [Full Text] [Related]  

  • 13. AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
    Joshita S; Umemura T; Ota M; Tanaka E
    J Hepatol; 2014 Dec; 61(6):1443-5. PubMed ID: 25152209
    [No Abstract]   [Full Text] [Related]  

  • 14. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 15. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
    Gluud C; Christensen E
    J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
    Schattenberg JM
    Gut; 2020 Aug; 69(8):1377-1378. PubMed ID: 32205421
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to: "AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis".
    Trivedi PJ; Bruns T; Li KK; Hirschfield GM
    J Hepatol; 2014 Dec; 61(6):1445-6. PubMed ID: 25152206
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of primary biliary cirrhosis: from diagnosis to end-stage disease.
    Lazaridis KN; Lindor KD
    Curr Gastroenterol Rep; 2000 Apr; 2(2):94-8. PubMed ID: 10981009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression.
    Paumgartner G
    J Hepatol; 2003 Jul; 39(1):112-4. PubMed ID: 12821052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.